Cytogenetic aberrations in neuropathy associated with IgM monoclonal gammopathy

Journal of the Neurological Sciences

Volumn 260, Issue 1-2, 2007, Pages 124-131

  Eurelings, Marijke ^a   Lokhorst, Henk M ^b   Notermans, Nicolette C ^a   Krijtenburg, Pieter Jaap ^b   Kessel, Berris van ^b   Eleveld, Mark J ^b   Bloem, Andries ^b   Wokke, John H ^a   Poot, Martin ^b   Buijs, Arjan ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CGH array; Cytogenetic aberrations; Interphase FISH; MLPA; Monoclonal gammopathy; Neuropathy

Indexed keywords

IMMUNOGLOBULIN M;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

AGED; B-LYMPHOCYTES; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 14; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; IMMUNOGLOBULIN M; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PARAPROTEINEMIAS; PERIPHERAL NERVES; POLYNEUROPATHIES; WALDENSTROM MACROGLOBULINEMIA;

EID: 34547690759     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.04.022     Document Type: Article

References (45)

1. Quarles R.H., and Weiss M.D. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 22 7 (1999) 800-822
2. Tatum A.H. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol 33 5 (1993) 502-506
3. Latov N. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol 37 Suppl 1 (1995) S32-S42
4. Kyle R.A. Monoclonal gammopathy of undetermined significance and solitary plasmocytoma. Hematol Oncol Clin North Am 11 1 (1997) 71-88
5. Owen R.G., Treon S.P., Al-Katib A., Fonseca R., Greipp P.R., McMaster M.L., et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 30 2 (2003) 110-115
6. Kyle R.A., Therneau T.M., Rajkumar S.V., Offord J.R., Larson D.R., Plevak M.F., et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346 8 (2002) 564-569
7. Eurelings M., Lokhorst H.M., Kalmijn S., Wokke J.H., and Notermans N.C. Malignant transformation in polyneuropathy associated with monoclonal gammopathy. Neurology 64 12 (2005) 2079-2084
8. Kyle R.A., Therneau T.M., Rajkumar S.V., et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 102 10 (2003) 3759-3764
9. Montoto S., Rozman M., Rosinol L., Nadal E., Gine E., Aymerich M., et al. Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Semin Oncol 30 2 (2003) 178-181
10. Drach J., Angerler J., Schuster J., Rothermundt C., Thalhammer R., Haas O.A., et al. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 86 10 (1995) 3915-3921
11. Ahmann G.J., Jalal S.M., Juneau A.L., Christensen E.R., Hanson C.A., Dewald G.W., et al. A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies. Cancer Genet Cytogenet 101 1 (1998) 7-11
12. Hallek M., Bergsagel P.L., and Anderson K.C. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 91 1 (1998) 3-21
13. Zojer N., Konigsberg R., Ackermann J., Fritz E., Dallinger S., Kromer E., et al. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood 95 6 (2000) 1925-1930
14. Konigsberg R., Ackermann J., Kaufmann H., Zojer N., Urbauer E., Kromer E., et al. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance. Leukemia 14 11 (2000) 1975-1979
15. Bergsagel P.L., and Kuehl W.M. Chromosome translocations in multiple myeloma. Oncogene 20 40 (2001) 5611-5622
16. Lloveras E., Sole F., Florensa L., Besses C., Espinet B., Gil M., et al. Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance. Cancer Genet Cytogenet 132 1 (2002) 25-29
17. Fonseca R., Bailey R.J., Ahmann G.J., Rajkumar S.V., Hoyer J.D., Lust J.A., et al. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood 100 4 (2002) 1417-1424
18. Avet-Loiseau H., Facon T., Grosbois B., Magrangeas F., Rapp M.J., Harousseau J.L., et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood 99 6 (2002) 2185-2191
19. Bernasconi P., Cavigliano P.M., Boni M., Astori C., Calatroni S., Giardini I., et al. Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance. Br J Haematol 118 2 (2002) 545-549
20. Fonseca R., Blood E., Rue M., Harrington D., Oken M.M., Kyle R.A., et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 101 11 (2003) 4569-4575
21. Kaufmann H., Ackermann J., Baldia C., Nosslinger T., Wieser R., Seidl S., et al. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma. Leukemia 18 11 (2004) 1879-1882
22. Panayiotidis P., and Kotsi P. Genetics of small lymphocyte disorders. Semin Hematol 36 2 (1999) 171-177
23. Vaandrager J.W., Schuuring E., Raap T., Philippo K., Kleiverda K., Kluin P., et al. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes Chromosomes Cancer 27 1 (2000) 85-94
24. Dave B.J., Nelson M., Pickering D.L., Chan W.C., Greiner T.C., Weisenburger D.D., et al. Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization. Cancer Genet Cytogenet 132 2 (2002) 125-132
25. Godon A., Moreau A., Talmant P., Baranger-Papot L., Genevieve F., Milpied N., et al. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia 17 1 (2003) 255-259
26. Okhowat R., Dorner S., Hinterberger W., and Fonatsch C. Unusual karyotype aberrations involving 2p12, 3q27, 18q21, 8q24, and 14q32 in a patient with non-Hodgkin lymphoma/acute lymphoblastic leukemia. Cancer Genet Cytogenet 142 1 (2003) 60-64
27. Barrans S.L., Evans P.A., O'Connor S.J., Owen R.G., Morgan G.J., and Jack A.S. The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clin Cancer Res 9 6 (2003) 2133-2139
28. Chang H., Samiee S., Li D., Patterson B., Chen C.I., and Stewart A.K. Analysis of IgH translocations, chromosome 13q14 and 17p13.1(p53) deletions by fluorescence in situ hybridization in Waldenstrom's macroglobulinemia: a single center study of 22 cases. Leukemia 18 6 (2004) 1160-1162
29. Notermans N.C., Wokke J.H., Franssen H., van der Graaf Y., Vermeulen M., van den Berg L.H., et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 56 10 (1993) 1066-1071
30. Baldini L., Goldaniga M., Guffanti A., Broglia C., Cortelazzo S., Rossi A., et al. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system. J Clin Oncol 23 21 (2005) 4662-4668
31. Notermans N.C., Lokhorst H.M., Franssen H., Van der Graaf Y., Teunissen L.L., Jennekens F.G., et al. Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance. Neurology 47 5 (1996) 1227-1233
32. Van den Berg L.H., Hays A.P., Nobile-Orazio E., Kinsella L.J., Manfredini E., Corbo M., et al. Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 19 5 (1996) 637-643
33. Van den Berg L.H., Lankamp C.L., de Jager A.E., Notermans N.C., Sodaar P., Marrink J., et al. Anti-sulphatide antibodies in peripheral neuropathy. J Neurol Neurosurg Psychiatry 56 11 (1993) 1164-1168
34. Jacobs B.C., Endtz H., van der Meche F.G., Hazenberg M.P., Achtereekte H.A., and Van Doorn P.A. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol 37 2 (1995) 260-264
35. Eurelings M., Ang C.W., Notermans N.C., Van Doorn P.A., Jacobs B.C., and Van den Berg L.H. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy. Neurology 57 10 (2001) 1909-1912
36. Jacobs J.M. Morphological changes at paranodes in IgM paraproteinaemic neuropathy. Microsc Res Tech 34 6 (1996) 544-553
37. Sahota S.S., Garand R., Mahroof R., Smith A., Juge-Morineau N., Stevenson F.K., et al. V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events. Blood 94 3 (1999) 1070-1076
38. Schop R.F., Kuehl W.M., Van Wier S.A., Ahmann G.J., Price-Troska T., Bailey R.J., et al. Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 100 8 (2002) 2996-3001
39. Vissers L.E., de Vries B.B., Osoegawa K., Janssen I.M., Feuth T., Choy C.O., et al. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 73 6 (2003) 1261-1270
40. Stone M.J., McElroy Y.G., Pestronk A., Reynolds J.L., Newman J.T., and Tong A.W. Human monoclonal macroglobulins with antibody activity. Semin Oncol 30 2 (2003) 318-324
41. Offit K., Parsa N.Z., Filippa D., Jhanwar S.C., and Chaganti R.S. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 80 10 (1992) 2594-2599
42. Taylor H.J., Gravett P., and Plowman P.N. Secondary acute myeloblastic leukaemia (AML) (expressing 11q23 mutation) occurring 11 months after chemotherapy/radiotherapy for paediatric non-Hodgkin lymphoma (NHL). Clin Oncol (R Coll Radiol) 12 2 (2000) 112-114
43. Lesesve J.F., Schneider P., Dolgopolov I., Bastard C., Lenormand B., Cambon-Michot E., et al. Therapy-related acute myeloid leukemia with t(8;21) in a child with previous Ewing's sarcoma. Med Pediatr Oncol 29 2 (1997) 132-134
44. Farhi D.C., Odell C.A., and Shurin S.B. Myelodysplastic syndrome and acute myeloid leukemia after treatment for solid tumors of childhood. Am J Clin Pathol 100 3 (1993) 270-275
45. Schop R.F., Van Wier S.A., Xu R., Ghobrial I., Ahmann G.J., Greipp P.R., et al. 6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance. Cancer Genet Cytogenet 169 2 (2006) 150-153